What Would You Do if You Could Sequence Everything?
Overview
Affiliations
It could be argued that the greatest transformative aspect of the Human Genome Project has been not the sequencing of the genome itself, but the resultant development of new technologies. A host of new approaches has fundamentally changed the way we approach problems in basic and translational research. Now, a new generation of high-throughput sequencing technologies promises to again transform the scientific enterprise, potentially supplanting array-based technologies and opening up many new possibilities. By allowing DNA/RNA to be assayed more rapidly than previously possible, these next-generation platforms promise a deeper understanding of genome regulation and biology. Significantly enhancing sequencing throughput will allow us to follow the evolution of viral and bacterial resistance in real time, to uncover the huge diversity of novel genes that are currently inaccessible, to understand nucleic acid therapeutics, to better integrate biological information for a complete picture of health and disease at a personalized level and to move to advances that we cannot yet imagine.
Nucleic acid-based drugs for patients with solid tumours.
Huayamares S, Loughrey D, Kim H, Dahlman J, Sorscher E Nat Rev Clin Oncol. 2024; 21(6):407-427.
PMID: 38589512 DOI: 10.1038/s41571-024-00883-1.
Wu L, Fredua-Agyeman R, Strelkov S, Chang K, Hwang S Int J Mol Sci. 2022; 23(17).
PMID: 36077139 PMC: 9456226. DOI: 10.3390/ijms23179744.
Multiple Variant Calling Pipelines in Wheat Whole Exome Sequencing.
Cagirici H, Akpinar B, Sen T, Budak H Int J Mol Sci. 2021; 22(19).
PMID: 34638743 PMC: 8509018. DOI: 10.3390/ijms221910400.
Using mechanistic models for the clinical interpretation of complex genomic variation.
Pena-Chilet M, Esteban-Medina M, Falco M, Rian K, Hidalgo M, Loucera C Sci Rep. 2019; 9(1):18937.
PMID: 31831811 PMC: 6908734. DOI: 10.1038/s41598-019-55454-7.
Using Large Datasets to Understand Nanotechnology.
Paunovska K, Loughrey D, Sago C, Langer R, Dahlman J Adv Mater. 2019; 31(43):e1902798.
PMID: 31429126 PMC: 6810779. DOI: 10.1002/adma.201902798.